001     172524
005     20240917143350.0
024 7 _ |a 10.1038/s41598-021-99409-3
|2 doi
024 7 _ |a pmid:34611289
|2 pmid
024 7 _ |a altmetric:114624743
|2 altmetric
037 _ _ |a DKFZ-2021-02072
041 _ _ |a English
082 _ _ |a 600
100 1 _ |a Escala-Garcia, Maria
|b 0
245 _ _ |a Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.
260 _ _ |a [London]
|c 2021
|b Macmillan Publishers Limited, part of Springer Nature
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1726576404_21166
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Breast cancer metastasis accounts for most of the deaths from breast cancer. Identification of germline variants associated with survival in aggressive types of breast cancer may inform understanding of breast cancer progression and assist treatment. In this analysis, we studied the associations between germline variants and breast cancer survival for patients with distant metastases at primary breast cancer diagnosis. We used data from the Breast Cancer Association Consortium (BCAC) including 1062 women of European ancestry with metastatic breast cancer, 606 of whom died of breast cancer. We identified two germline variants on chromosome 1, rs138569520 and rs146023652, significantly associated with breast cancer-specific survival (P = 3.19 × 10-8 and 4.42 × 10-8). In silico analysis suggested a potential regulatory effect of the variants on the nearby target genes SDE2 and H3F3A. However, the variants showed no evidence of association in a smaller replication dataset. The validation dataset was obtained from the SNPs to Risk of Metastasis (StoRM) study and included 293 patients with metastatic primary breast cancer at diagnosis. Ultimately, larger replication studies are needed to confirm the identified associations.
536 _ _ |a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|0 G:(DE-HGF)POF4-313
|c POF4-313
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo01.inet.dkfz-heidelberg.de
700 1 _ |a Canisius, Sander
|b 1
700 1 _ |a Keeman, Renske
|b 2
700 1 _ |a Beesley, Jonathan
|b 3
700 1 _ |a Anton-Culver, Hoda
|b 4
700 1 _ |a Arndt, Volker
|0 P:(DE-He78)d023fdf423d87ee6c710e34dd7581fa0
|b 5
|u dkfz
700 1 _ |a Augustinsson, Annelie
|b 6
700 1 _ |a Becher, Heiko
|b 7
700 1 _ |a Beckmann, Matthias W
|b 8
700 1 _ |a Behrens, Sabine
|0 P:(DE-He78)6b04712f3afe72044d496a25505cb1ea
|b 9
|u dkfz
700 1 _ |a Bermisheva, Marina
|b 10
700 1 _ |a Bojesen, Stig E
|b 11
700 1 _ |a Bolla, Manjeet K
|b 12
700 1 _ |a Brenner, Hermann
|0 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
|b 13
|u dkfz
700 1 _ |a Canzian, Federico
|0 P:(DE-He78)5323704270b6393dcea70186ffd86bca
|b 14
|u dkfz
700 1 _ |a Castelao, Jose E
|b 15
700 1 _ |a Chang-Claude, Jenny
|0 P:(DE-He78)c259d6cc99edf5c7bc7ce22c7f87c253
|b 16
|u dkfz
700 1 _ |a Chanock, Stephen J
|b 17
700 1 _ |a Couch, Fergus J
|b 18
700 1 _ |a Czene, Kamila
|b 19
700 1 _ |a Daly, Mary B
|b 20
700 1 _ |a Dennis, Joe
|b 21
700 1 _ |a Devilee, Peter
|b 22
700 1 _ |a Dörk, Thilo
|b 23
700 1 _ |a Dunning, Alison M
|b 24
700 1 _ |a Easton, Douglas F
|b 25
700 1 _ |a Ekici, Arif B
|b 26
700 1 _ |a Eliassen, A Heather
|b 27
700 1 _ |a Fasching, Peter A
|b 28
700 1 _ |a Flyger, Henrik
|b 29
700 1 _ |a Gago-Dominguez, Manuela
|b 30
700 1 _ |a García-Closas, Montserrat
|b 31
700 1 _ |a García-Sáenz, José A
|b 32
700 1 _ |a Geisler, Jürgen
|b 33
700 1 _ |a Giles, Graham G
|b 34
700 1 _ |a Grip, Mervi
|b 35
700 1 _ |a Gündert, Melanie
|0 P:(DE-HGF)0
|b 36
700 1 _ |a Hahnen, Eric
|b 37
700 1 _ |a Haiman, Christopher A
|b 38
700 1 _ |a Håkansson, Niclas
|b 39
700 1 _ |a Hall, Per
|b 40
700 1 _ |a Hamann, Ute
|0 P:(DE-He78)537e07b3e57b16c7b214fc2242e4326b
|b 41
|u dkfz
700 1 _ |a Hartikainen, Jaana M
|b 42
700 1 _ |a Heemskerk-Gerritsen, Bernadette A M
|b 43
700 1 _ |a Hollestelle, Antoinette
|b 44
700 1 _ |a Hoppe, Reiner
|b 45
700 1 _ |a Hopper, John L
|b 46
700 1 _ |a Hunter, David J
|b 47
700 1 _ |a Jacot, William
|b 48
700 1 _ |a Jakubowska, Anna
|b 49
700 1 _ |a John, Esther M
|b 50
700 1 _ |a Jung, Audrey Y
|0 P:(DE-He78)bce1fdec5ce564e2666156d96aeabec9
|b 51
|u dkfz
700 1 _ |a Kaaks, Rudolf
|0 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a
|b 52
|u dkfz
700 1 _ |a Khusnutdinova, Elza
|b 53
700 1 _ |a Koppert, Linetta B
|b 54
700 1 _ |a Kraft, Peter
|b 55
700 1 _ |a Kristensen, Vessela N
|b 56
700 1 _ |a Kurian, Allison W
|b 57
700 1 _ |a Lambrechts, Diether
|b 58
700 1 _ |a Le Marchand, Loic
|b 59
700 1 _ |a Lindblom, Annika
|b 60
700 1 _ |a Luben, Robert N
|b 61
700 1 _ |a Lubiński, Jan
|b 62
700 1 _ |a Mannermaa, Arto
|b 63
700 1 _ |a Manoochehri, Mehdi
|0 P:(DE-He78)16b8745cffb0db0d366978d3afe17ebc
|b 64
|u dkfz
700 1 _ |a Margolin, Sara
|b 65
700 1 _ |a Mavroudis, Dimitrios
|b 66
700 1 _ |a Muranen, Taru A
|b 67
700 1 _ |a Nevanlinna, Heli
|b 68
700 1 _ |a Olshan, Andrew F
|b 69
700 1 _ |a Olsson, Håkan
|b 70
700 1 _ |a Park-Simon, Tjoung-Won
|b 71
700 1 _ |a Patel, Alpa V
|b 72
700 1 _ |a Peterlongo, Paolo
|b 73
700 1 _ |a Pharoah, Paul D P
|b 74
700 1 _ |a Punie, Kevin
|b 75
700 1 _ |a Radice, Paolo
|b 76
700 1 _ |a Rennert, Gad
|b 77
700 1 _ |a Rennert, Hedy S
|b 78
700 1 _ |a Romero, Atocha
|b 79
700 1 _ |a Roylance, Rebecca
|b 80
700 1 _ |a Rüdiger, Thomas
|b 81
700 1 _ |a Ruebner, Matthias
|b 82
700 1 _ |a Saloustros, Emmanouil
|b 83
700 1 _ |a Sawyer, Elinor J
|b 84
700 1 _ |a Schmutzler, Rita K
|b 85
700 1 _ |a Schoemaker, Minouk J
|b 86
700 1 _ |a Scott, Christopher
|b 87
700 1 _ |a Southey, Melissa C
|b 88
700 1 _ |a Surowy, Harald
|0 P:(DE-He78)ec311cea9d07f894e44d05a570e26e28
|b 89
700 1 _ |a Swerdlow, Anthony J
|b 90
700 1 _ |a Tamimi, Rulla M
|b 91
700 1 _ |a Teras, Lauren R
|b 92
700 1 _ |a Thomas, Emilie
|b 93
700 1 _ |a Tomlinson, Ian
|b 94
700 1 _ |a Troester, Melissa A
|b 95
700 1 _ |a Vachon, Celine M
|b 96
700 1 _ |a Wang, Qin
|b 97
700 1 _ |a Winqvist, Robert
|b 98
700 1 _ |a Wolk, Alicja
|b 99
700 1 _ |a Ziogas, Argyrios
|b 100
700 1 _ |a Investigators, kConFab/AOCS
|b 101
|e Collaboration Author
700 1 _ |a Michailidou, Kyriaki
|b 102
700 1 _ |a Chenevix-Trench, Georgia
|b 103
700 1 _ |a Bachelot, Thomas
|b 104
700 1 _ |a Schmidt, Marjanka K
|b 105
773 _ _ |a 10.1038/s41598-021-99409-3
|g Vol. 11, no. 1, p. 19787
|0 PERI:(DE-600)2615211-3
|n 1
|p 19787
|t Scientific reports
|v 11
|y 2021
|x 2045-2322
909 C O |p VDB
|o oai:inrepo02.dkfz.de:172524
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 5
|6 P:(DE-He78)d023fdf423d87ee6c710e34dd7581fa0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 9
|6 P:(DE-He78)6b04712f3afe72044d496a25505cb1ea
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 13
|6 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 14
|6 P:(DE-He78)5323704270b6393dcea70186ffd86bca
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 16
|6 P:(DE-He78)c259d6cc99edf5c7bc7ce22c7f87c253
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 36
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 41
|6 P:(DE-He78)537e07b3e57b16c7b214fc2242e4326b
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 51
|6 P:(DE-He78)bce1fdec5ce564e2666156d96aeabec9
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 52
|6 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 64
|6 P:(DE-He78)16b8745cffb0db0d366978d3afe17ebc
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 89
|6 P:(DE-He78)ec311cea9d07f894e44d05a570e26e28
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-313
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Krebsrisikofaktoren und Prävention
|x 0
914 1 _ |y 2021
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b SCI REP-UK : 2019
|d 2021-02-03
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2021-02-03
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2021-02-03
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2021-02-03
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2021-02-03
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2021-02-03
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Blind peer review
|d 2021-02-03
915 _ _ |a Creative Commons Attribution CC BY (No Version)
|0 LIC:(DE-HGF)CCBYNV
|2 V:(DE-HGF)
|b DOAJ
|d 2021-02-03
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2021-02-03
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2021-02-03
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2021-02-03
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-02-03
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2021-02-03
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1150
|2 StatID
|b Current Contents - Physical, Chemical and Earth Sciences
|d 2021-02-03
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1040
|2 StatID
|b Zoological Record
|d 2021-02-03
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2021-02-03
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-02-03
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2021-02-03
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2021-02-03
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2021-02-03
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2021-02-03
920 1 _ |0 I:(DE-He78)C071-20160331
|k C071
|l C071 Cancer Survivorship
|x 0
920 1 _ |0 I:(DE-He78)C070-20160331
|k C070
|l C070 Klinische Epidemiologie und Alternf.
|x 1
920 1 _ |0 I:(DE-He78)C020-20160331
|k C020
|l C020 Epidemiologie von Krebs
|x 2
920 1 _ |0 I:(DE-He78)C120-20160331
|k C120
|l Präventive Onkologie
|x 3
920 1 _ |0 I:(DE-He78)HD01-20160331
|k HD01
|l DKTK HD zentral
|x 4
920 1 _ |0 I:(DE-He78)C055-20160331
|k C055
|l Genomische Epidemiologie
|x 5
920 1 _ |0 I:(DE-He78)C080-20160331
|k C080
|l Molekulare Epidemiologie
|x 6
920 1 _ |0 I:(DE-He78)B072-20160331
|k B072
|l Molekulargenetik des Mammakarzinoms
|x 7
920 1 _ |0 I:(DE-He78)B070-20160331
|k B070
|l B070 Funktionelle Genomanalyse
|x 8
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C071-20160331
980 _ _ |a I:(DE-He78)C070-20160331
980 _ _ |a I:(DE-He78)C020-20160331
980 _ _ |a I:(DE-He78)C120-20160331
980 _ _ |a I:(DE-He78)HD01-20160331
980 _ _ |a I:(DE-He78)C055-20160331
980 _ _ |a I:(DE-He78)C080-20160331
980 _ _ |a I:(DE-He78)B072-20160331
980 _ _ |a I:(DE-He78)B070-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21